Cargando…
469. Outcomes of COVID-19 among hospitalized patients under Rituximab: the experience of a Portuguese hospital
BACKGROUND: Rituximab (RTX) is a monoclonal antibody commonly used for various hematological and autoimmune disorders. B-cell–depleting therapies also blunt humoral responses to SARS-CoV-2 vaccines. Whether this carries an increased risk of hospitalization or death from COVID-19 is unclear. METHODS:...
Autores principales: | Gonçalves, Maria João M S, Pena, Eduarda, Duarte, Frederico, Oliveira, Susana, Batista, Clara, Guimarães, Mário, Abreu, Ricardo Correia, Neves, Isabel, Jordão, Sofia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677196/ http://dx.doi.org/10.1093/ofid/ofad500.539 |
Ejemplares similares
-
921. Clinical characteristics of hospitalized adults with herpes zoster in a Portuguese hospital: 11 years of experience
por: Pena, Eduarda, et al.
Publicado: (2023) -
A rare cause of vertebral osteomyelitis: the first case report of
rat-bite fever in Portugal
por: Pena, Eduarda, et al.
Publicado: (2019) -
Organizational Commitment and Intention to Leave of Nurses in Portuguese Hospitals
por: Neves, Teresa, et al.
Publicado: (2022) -
Methylation analysis of Klebsiella pneumoniae from Portuguese hospitals
por: Spadar, Anton, et al.
Publicado: (2021) -
Dengue virus serotype 3 and Chikungunya virus co-infection in a traveller returning from India to Portugal, November 2016
por: Paulo, Catarina Oliveira, et al.
Publicado: (2017)